Beyond the Naïve “No‐See”: Ethical Prescribing and the Drive for Pharmaceutical Transparency

  title={Beyond the Na{\"i}ve “No‐See”: Ethical Prescribing and the Drive for Pharmaceutical Transparency},
  author={Michael Oldani},

Shadow science: Zyprexa, Eli Lilly and the globalization of pharmaceutical damage control

Ethnicographic research in Japan is drawn on to describe how Lilly dealt with the threat to the brand equity of Zyprexa there, and how they sought to keep their global marketing program for the drug on course.

The physician's relationship with the pharmaceutical industry: caveat emptor...buyer beware!

The intention in raising the consciousness of physicians and medical institutions to these potential areas of concern is to aid physicians in their efforts to provide the best medical care for patients and to practice with integrity.

Patient and practitioner noncompliance: rationing, therapeutic uncertainty, and the missing conversation

  • C. Rouse
  • Psychology
    Anthropology & medicine
  • 2010
This paper argues that behavioral explanations for health care disparities shift attention away from structural issues, namely health care rationing and the limits of therapeutic medicine.

Examining Reports and Policies on Cognitive Enhancement: Approaches, Rationale, and Recommendations

It is found that cognitive enhancement is constituted in a way that challenges the creation of coherent and effective policy recommendations, and policy makers should not simply wait for definitional consensus and hope that on balance the benefits turn out to be greater than the risks.

Changing Diagnostic and Treatment Criteria for Chronic Illness: A Critical Consideration of their Impact on Low-Income Hispanic Patients.

This paper critically review recent changes in diabetes, hypertension and high cholesterol diagnostic and treatment standards which have dramatically increased the number of people being treated for these conditions, and examines how these new standards are being applied and the resulting health care challenges these Hispanic patients face.

Combining quantitative and qualitativemethods in signal detection andevaluation in pharmacovigilance.

Combining traditional, qualitative review of pre-marketing information with quantitative, signal detection methodology has the potential to improve Pharmacovigilance, allowing quick, accurate identification of safety risks to monitor for marketed medicinal products.

Towards an era of bureaucratically controlled medical compliance ?

  • 2010



Global Pharmaceuticals: Ethics, Markets, Practices

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole

Generation Rx: How prescription drugs are altering American lives, minds, and bodies

The growth of the pharmaceutical industry and the general willingness of the public to accept prescription medications for themselves and their children are outlined and the three “pharmaceutical tribes” of the American public are described.

Global Pharmaceuticals: Ethics, Markets, Practices

This collection of essays on the ethics, marketing, and practices of global pharmaceuticals provides detailed insights into many aspects of the pharmaceutical business and the use of medicines. In an

Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota.

The Vermont and Minnesota laws requiring disclosure of payments do not provide easy access to payment information for the public and are of limited quality once accessed.

Thick prescriptions: toward an interpretation of pharmaceutical sales practices.

This article ethnographically explores one particular stage in the life cycle of pharmaceuticals: sales and marketing, and describes in detail the pharmaceutical gift cycle, a three-way exchange network between doctors, salespersons, and patients and how this process of exchange is currently in a state of involution.

A historical perspective of pharmaceutical promotion and physician education.

This Commentary traces the problem of commercial influence on physician education from the advent of the wonder drugs through current concerns regarding formal CME, with particular attention to a critical period in the late 1950s and early 1960s during which most positions in the current debate were firmly established.

Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression.

Assistant Editor’s Note:Most manuscripts submitted to the Journal arrive unsolicited. By contrast, book reviews are presumably by-invitation-only affairs. A corollary is that when this general

Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry

The Tipping Point, a story of two Medications and the Ugly: A Story of Two Medications, is a guide to the pharmaceutical industry, 1990-2004, and the challenges and opportunities facing the industry today.

Killer Commodities: Public Health and the Corporate Production of Harm

Chapter 1 Introduction: Hidden Harm: The Complex World of Killer Commodities Chapter 2 Stealthy Killers and Governing Mentalities: Chemicals in Consumer Products Chapter 3 Nothing to Play Around

Filling scripts: A multi-sited ethnography of pharmaceutical sales practices, psychiatric prescribing, and phamily life in North America

This dissertation is an ethnographic examination of the standard pharmaceutical prescription narrative (the standard pharmaceutical script). It focuses on the double meaning of